Regencell Bioscience Holdings Ltd (RGC) stock chart

RGCNasdaqMedicinal Chemicals & Botanical Products

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30

$4.94−0.18 (-3.61%)

Close on Nov 13, 2026Market cap $2.45BP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?